LSD, Anxiety, Depression and Brain Entropy
LSD
has recently become of interest again after a prolonged break since the
early 1970ies (Liechti, 2017). A study has found that six to eight
psychotherapy sessions, accompanied by two sessions where LSD has been
administrated in a controlled environment, effectively lowered anxiety
in patients with a terminal or life-threatening disease (Gasser,
Kirchner & Passie, 2015). Patients with ongoing severe diseases
often suffer from depression, isolation and substantial anxiety. Two
thirds of those patients involved in the study experienced less fear of
death and a rise in the quality of life. They felt more patience,
experienced less inner withdrawal and more openness and acceptance for
their situation. The entropic brain theory states that psychedelic
experiences put the brain in an entropic state. Brain areas that are
usually not connected with each other communicate in a chaotic manner
(Carhart-Harris et al., 2014). In patients with depression, OCD and
addiction this might help to snap the brain out of its default mode
where the same old pathways are used and a patient gets entrenched in
habit. Entropy is creating chaos within those entrenched habits and
through its innate uncertainty connects parts of the brain and creates
new patterns. Is has been found that psilocybin and LSD can have
positive effects on depression (Stroud et al., 2017).
References
Carhart-Harris, R., Leech, R., Hellyer, P., Shanahan, M., Feilding, A., Tagliazucchi, E., Chialvo, D. R. & Nutt, D. (2014). The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs. Frontiers in Human Neuroscience 8:20. doi: 10.3389/fnhum.2014.00020
Gasser, P., Kirchner, K., & Passie, T. (2015). LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects. Journal of Psychopharmacology Vol. 29(1) 57–6. DOI: 10.1177/0269881114555249
Liechti, M. E. (2017). Review: Modern Clinical Research on LSD. Neuropsychopharmacology, 42, 2114–2127. doi:10.1038/npp.2017.86
Stroud, J.B., Freeman, T. P., Leech R., Hindocha, C., Lawn, W., Nutt, D., Curran, H.V., Carhart-Harris, R. L. (2018). Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression. Psychopharmacology, 235:459–466 https://doi.org/10.1007/s00213-017-4754-y
Comments
Post a Comment